Posts

Siemens Healthineers & Qure.ai partnership Aims to Enha...

Siemens Healthineers, in collaboration with Qure.ai and the Global Fund to Comba...

Meilleur partners with ADNI4 for next-generation Alzhei...

US biopharma company Meilleur Technologies has entered a research collaboration...

Roche posts 7% rise in Q3 2023 group sales

Roche has posted a 7% rise in group sales to SFr14.27bn ($15.91bn) at constant ...

EC grants approval to Pfizer for $43bn Seagen acquisition 

The European Commission (EC) has granted unconditional approval to Pfizer for i...

Tourmaline shifts focus to developing anti-IL6 antibody...

Tourmaline Bio has completed the merger with Talaris Therapeutics and will begi...

AI will severely impact almost a fifth of jobs, Indeed ...

Artificial intelligence (AI) is going to effect almost a fifth of jobs at the hi...

Over 20,000 UK businesses at risk of Chinese espionage,...

Over 20,000 people and businesses in the UK have already been approached by Chin...

Lipella gets go-ahead for trial studying chronic oral c...

US-based clinical-stage biotechnology company, Lipella, has announced US Food a...

NVIDIA banks on generative AI to pursue partnerships wi...

The growing use of generative artificial intelligence (genAI) is causing a “tit...

FDA clears UCB’s Bimzelx for psoriasis treatment

The US Food and Drug Administration (FDA) has approved UCB’s BIMZELX (bimekizum...

MSD signs Daiichi Sankyo in multibillion dollar deal to...

Merck & Co (MSD) has entered an agreement to develop and commercialise three of...

STAT+: Eli Lilly, riding a hot streak, expects to doubl...

Eli Lilly said this week that the genetic medicine research center it plans to o...

How an ER doctor in Chicago is tackling trauma from gun...

Abdullah Pratt uses develops programs that engage the youth in the community, in...

Why Biogen is purposefully becoming more risk averse, a...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: China arrests an Astellas exec acc...

China formally arrested an Astellas Pharma executive from Japan who had been det...

STAT+: Lilly complains to the U.S. International Trade ...

The drug maker maintained the companies are marketing "low grade" versions of pr...